期刊文献+

免疫毒素IL-3-PE38KDEL的表达及活性测定 被引量:2

Expression and activity detection of IL3-PE38KDEL
下载PDF
导出
摘要 目的:制备具有杀伤活性的新型抗白血病免疫毒素。方法:在异丙基硫代-β-D-半乳糖苷(Isopropyl-beta-D-throgalac-top yranoside,IPTG)的诱导下,高效表达免疫毒素IL3-PE38KDEL,采用细胞毒性实验,对毒素活性进行检测。结果:免疫毒素IL3-PE38KDEL以包涵体形式为主高效表达,该蛋白具有较好的毒素活性。结论:免疫毒素IL3-PE38KDEL具有良好的生物学活性,为其作为抗白血病药物的进一步研究打下了基础。 Objective:To prepare a new type of anti-leukemia immunotoxin with killing activity Methods:The method of cytotoxicity was used to study the activity of the immunotoxin after the induction of IPTG. Results :The expressed fusion proteins were detected mostly as inclusion bodies at high level.The result showed IL3-PE38KDEL had liable activity of toxicity. Conclusion: The fusion protein IL3-PE38KDEL has good biological activity,which paves way for the further study on its treatment of leukemia.
出处 《重庆医科大学学报》 CAS CSCD 2008年第11期1362-1364,共3页 Journal of Chongqing Medical University
关键词 白介素3 假单胞菌外毒素 免疫毒素 Human interleukin-3 Pseudomonas exotoxin(PE38KDEL) Immunotoxin
  • 相关文献

参考文献6

二级参考文献26

  • 1李虹,李明远,蒋忠华,吕梅励,张林.IL-18-PE38重组免疫毒素的原核表达及其鉴定[J].四川大学学报(医学版),2004,35(6):753-756. 被引量:4
  • 2Vallera D A, Burns L J, Frankel A E, et al. Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies[J]. J Immunol Methods, 1996, 197(1-2): 69-83.
  • 3Wels W, Biburger M, Muller T, et al. Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors[J]. Cancer Immunol Immunother, 2004, 53(3): 217-226.
  • 4Chen S Y, Marasco W A. Novel genetic immunotoxins and intracellular antibodies for cancer therapy [J]. Semin Oncol, 1996, 23(1): 148-153.
  • 5FitzGerald D J, Kreitman R, Wilson W, et al. Recombinant immunotoxins for treating cancer [J]. Int J Med Microbiol, 2004, 293(7-8): 577-582.
  • 6Kreitman R J. Chimeric fusion proteins-Pseudomonas exotoxin-based[J]. Curr Opin Investig Drugs, 2001, 2(9): 1282-1293.
  • 7Nagayoshi R, Nagai T, Matsushita K, et al. Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages[J]. Arthritis Rheum, 2005, 52(9): 2666-2675.
  • 8Posey J A, Khazaeli M B, Bookman M A, et al. A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors[J]. Clin Cancer Res, 2002, 8(10): 3092-3099.
  • 9Pastan I , Beers R, Bera T K. Recombinant immunotoxins in the treatment of cancer [J]. Methods Mol Biol, 2004, 248: 503-518.
  • 10Piao W H, Song X G, Liu M C, et al. Cloning, expression, and purification of HLA-A2-BSP and beta-2m in Escherichia coli[J].Protein Expr Purif, 2004, 35(2): 210-217.

共引文献7

同被引文献12

  • 1崔京霞,纪剑飞,倪剑锋,吴文芳.重组铜绿假单胞菌外毒素PE38KDEL的克隆、表达与活性检测[J].中华微生物学和免疫学杂志,2004,24(12):985-990. 被引量:4
  • 2江浩,刘开彦,童春容,江滨,陆道培.化疗联合自体细胞因子诱导杀伤细胞治疗急性白血病的临床观察[J].中华内科杂志,2005,44(3):198-201. 被引量:32
  • 3Campana D.Should minimal residual disease monitoring in acutelymphoblastic leukemia be standard of care?[J].Curr Hematol Malig Rep, 2012,7(2) : 170-177.
  • 4Leemhuis T, Wells S,Scheffold C,et al.A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma[J].Biol Blood Marrow Tramplant, 2005,11 (3) : 181-187.
  • 5Linn Y C,Hui K M.Cytokine-induced killer cells:NK-like T cells with cytotolytic specificity against leukemia[J].Leuk Lymphoma, 2003, 44(9) : 1457-1462.
  • 6Introna M,Franceschetti M,Ciocca A,et al.Rapid and massive ex- pansion of cord blood-derived cytokine-induced killer cells:an inno- vative proposal for the treatment of leukemia relapse after cord blood transplantation[J].Bone Marrow Transplant, 2006,38 (9) : 621-627.
  • 7Potala S,Sahoo S K,Verma R S.Targeted therapy of cancer using diphtheria toxin-derived immunotoxins[J].Drug Discov Today,2008,13 (17-18) :807-815.
  • 8Kim H P,rankel A E,Hogge D E.A diphtheria toxin interleukin- 3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia [J].Leuk Res,2010,34(8) : 1035-1042.
  • 9Introna M,Franeesehetti M,Ciocea A,et al.Rapid and massive ex- pansion of cord blood-derived cytokine-induced killer cells:an inno- vative proposal for the treatment of leukemia relapse after cord blood transplantation[J].Bone Marrow Transplant, 2006,38 (9) : 621-627.
  • 10夏卫,郁心,王浦南,徐洪卫,陈宇,奚华新,杨吉成,缪竞诚.IL-24基因修饰增强CIK细胞对HL-60细胞的细胞毒作用[J].中国免疫学杂志,2009,25(12):1080-1084. 被引量:4

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部